Phreesia, Inc. (PHR) is a Medical - Healthcare Information Services company in the Healthcare sector, currently trading at $8.60. It has a SharesGrow Score of 58/100, indicating a above average investment profile with 3 out of 7 criteria passed.
SharesGrow calculates the intrinsic value of PHR = $544.71 (+6233.8% from the current price, the stock appears undervalued). Analyst consensus target is PHR = $28 (+219.8% upside).
Valuation: PHR trades at a trailing Price-to-Earnings (P/E) of 216.8 (S&P 500 average ~25) with a forward Price/Earnings-to-Growth (PEG) of 2.63.
Financials: revenue is $481M, +19.7%/yr average growth. Net income is $20M (loss), growing at +48.3%/yr. Net profit margin is -4.2% (negative). Gross margin is 85.2% (+24.1 pp trend).
Balance sheet: total debt is $93M against $337M equity (Debt-to-Equity (D/E) ratio 0.28, conservative). Current ratio is 1.53 (strong liquidity). Debt-to-assets is 14%. Total assets: $664M.
Analyst outlook: 20 / 25 analysts rate PHR as buy (80%) — strong consensus.
SharesGrow 7-Criteria breakdown: Value 50/100 (Partial), Growth 90/100 (Pass), Past 0/100 (Fail), Health 100/100 (Pass), Moat 64/100 (Partial), Future 94/100 (Pass), Income 10/100 (Fail).
